Omnipod® Reviews
Real stories of lives made simpler.
Thousands of Omnipod users remember what life with diabetes was like before discovering the tubeless, waterproof*, wearable insulin Pod. Check out real stories of how Omnipod has made meaningful differences, both big and small.
This page contains real testimonials by sponsored users.
Omnipod 5 Automated Insulin Delivery System
Christian D.
Six-year-old Christian loves to swim, hoverboard, and hang out with his sisters. And his parents love that with Omnipod 5, type 1 diabetes doesn’t stop him from just being a kid.
The Kruegers
Sisters Belle, Ana, and Sophia live with a built-in type 1 diabetes support system – each other! From playing sports to heading off to college, Omnipod 5 plays a key role in their family’s diabetes management.
April B.
April has a complex career as an aerospace engineer, and after spending much of her life with type 1 diabetes using an insulin pump with tubes, she’s embracing newfound freedom with Omnipod 5 – for herself, and her family.
Omnipod DASH® Insulin Delivery System
Ready to take the next step?
Choose your path and answer a few questions to find out which Omnipod product‡ is best for you. It’s that easy.
Once complete, a member of the Omnipod Pharmacy support team§ will reach out with your expected copay and free trial# eligibility.
I’d like to check my coverage
Find out your estimated copay
I'd like a free trial of Omnipod#
Take the Pod for a test drive
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.waterproof.
†The Omnipod 5 System was named 2023 Patient Choice Award Winner for preferred pump in the United States; Seagrove Patient Perspectives Survey Report (413 Total Responses, 260 T1D, 153 T2D - 245 pumpers, 98 MDI, 70 non-MDI). Seagrove Partners, LLC Patient Perspectives Report, December 2023. Insulet data on file.
‡ Available products subject to current insurance coverage and product indication for use. Insulet can only support onboarding for those customers within the product indication. The Omnipod® 5 System is currently indicated for use by individuals with type 1 diabetes, 2 years of age and older. Omnipod DASH® is currently indicated for all insulin-requiring users.
§ ASPN Pharmacies and its dedicated staff power the Omnipod Pharmacy Support Program. The ASPN team is here for you to check your coverage and help coordinate fulfillment at your pharmacy of choice.
#Omnipod DASH® 30-Day Free Trial
Terms and Conditions
1. Program Eligibility
Eligibility criteria: Subject to program limitations and terms and conditions, the Omnipod DASH 30-day Free Trial Program (the “Program”) is open to patients who have a valid Omnipod DASH prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. The Program is open only to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod® 5, Omnipod DASH or Omnipod Insulin Management System.
This offer is not valid for participants whose Omnipod DASH prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs, or where prohibited by law. Participants on certain commercial insurance plans may not be eligible. This offer is only valid in the United States, Puerto Rico, and the U.S. territories. Please contact Insulet Customer Support at 1-800-591-3455 for details.
2. Program Details
With this program, Participants may be eligible to receive a 30-day supply of Omnipod DASH products at no cost for them. Eligible participants have two (2) options, based on the following:
• A participant shall sign the 30-day Omnipod DASH Free Trial Acknowledgement through the appropriate platform provided by pharmacy partner.
• Once Insulet, or its pharmacy partner, has received the request, including a valid prescription for the Omnipod DASH Intro Kit and Omnipod DASH Pods, the participant’s benefits will be checked by Insulet or its pharmacy partner.
• If the benefits check results in a monthly copay equal to or below two hundred dollars ($200), then Insulet, or its pharmacy partner, shall issue a one-time only copay card to the participant, for a value equal to the out-of-pocket expenses the participant would have to pay for an Omnipod DASH 30-day initial shipment, in accordance with Section 3, below.
• If the benefits check result in a copay greater than two hundred dollars ($200), Insulet, or its authorized partners, shall arrange for the shipment of one (1) Omnipod DASH Intro Kit, in accordance with Section 4, below.
• For the purpose of clarity, the term “copay” shall encompass any out-of-pocket expense for one (1) month’s supply of Pods, including any deductible, copays and other out-of-pocket expenses that the participant would have to disburse to procure said supply of Pods.
• Any copay assistance may not apply to a participant’s health plan’s deductible if prohibited by state law or by a health plan.
Insulet reserves the right to change, amend or rescind this Program, in whole or in part, at any time.
3. Copay Card
Should participant be deemed eligible to receive an Omnipod DASH Copay Card, participant shall receive electronically one (1) Omnipod DASH Copay Card, valid for a single use, in the amount required for the participant to procure a 30-day supply of Omnipod DASH Pods at a participating pharmacy. In addition, pharmacy partners shall ship, at no cost to participant, one (1) Omnipod DASH Starter Kit, which shall include:
• One (1) Omnipod DASH Personal Diabetes Manager (PDM)
• One (1) Omnipod DASH User Guide
• One (1) PDM charging cable
4. Product Dispense
Should participant be deemed eligible to receive a one-time dispense of Omnipod DASH Pods at no cost to them, Insulet, or its authorized partner, shall dispense one (1) Omnipod DASH Intro Kit, which shall include:
• One (1) Omnipod DASH PDM
• Eleven (11) Omnipod DASH Pods
• One (1) Omnipod DASH User Guide
• One (1) PDM charging cable
The Omnipod DASH Intro Kit shall be delivered to the shipping address indicated by participant in their Acknowledgment Form. Any estimate date of delivery is given solely for participant’s information and does not constitute a warranty that the Intro Kit will be delivered on said date. Participant is responsible to provide an accurate delivery address, to receive shipment of the Intro Kit and to verify the content of the Intro Kit.
#Omnipod® 5 10-Day Free Trial
Terms and Conditions
1. Program Eligibility
Eligibility criteria: Subject to program limitations and terms and conditions, the Omnipod 5 10-day Free Trial Program (the “Program”) is open to patients who have a valid Omnipod 5 and Dexcom G6 prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. In order to be eligible, the patient’s eligible insurance plan must include coverage for Omnipod 5 Pods. The Program is open to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod 5, Omnipod DASH®️ or Omnipod Insulin Management System.
This offer is not valid for participants whose Omnipod 5 or Dexcom G6 prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. It is not valid for cash-paying participants or where prohibited by law. A participant is considered cash-paying where the participant has no insurance coverage for Omnipod 5 or where the participant has commercial or private insurance but determines in its sole discretion the participant is effectively uninsured because such coverage does not provide a material level of financial assistance for the cost of an Omnipod 5 prescription. Participants on certain commercial insurance plans may not be eligible. This offer is only valid in the United States, Puerto Rico, and the U.S. territories. Participants receiving their products through the Durable Medical Equipment or Pharmacy Durable Medical Equipment channel are not eligible to participate in the copay card program. Please contact Customer Support at 1-800-591-3455 for details.
2. Program Details
With this program, Participants may be eligible to receive a limited supply of Omnipod 5 products at no cost for them. Eligible participants have two (2) options, based on the following:
• A participant shall sign the Try Omnipod 5 Free Trial Acknowledgement through the appropriate platform provided.
• Once has received the request, the request shall be escalated to pharmacy partner, where a request for a prescription shall be sent to the participant’s healthcare professional. If a valid prescription is received, both for the Omnipod 5 Intro Kit and the Omnipod 5 Pods, the participant’s benefits will be checked by its partners.
• IF the benefits check results in a monthly copay equal to or below two hundred dollars ($200), then shall issue a one-time only copay card to the participant, for a value equal to the out-of-pocket expenses the participant would have to pay for an Omnipod 5 Intro Kit, in accordance with Section 3, below.
• IF the benefits check result in a copay greater than two hundred dollars ($200), or its authorized partners, shall arrange for the shipment of one (1) Omnipod 5 Intro Kit, in accordance with Section 4, below.
• For the purpose of clarity, the term “copay” shall encompass any out-of-pocket expense for one (1) month’s supply of Pods, including any deductible, copays and other out-of-pocket expenses that the participant would have to disburse to procure said supply of Pods.
• Any copay assistance may not apply to a participant’s health plan’s deductible if prohibited by state law or by a health plan.
• In order to use the Omnipod 5 System in Automated Mode, the User must also procure a Dexcom G6 Continuous Glucose Monitor System. For more information about how to obtain a 10-day supply of Dexcom G6, please contact Dexcom or click on the following link: http://www.dexcom.com/SampleOP5.
Reserves the right to change, amend or rescind this Program, in whole or in part, at any time.
3. Copay Card
Should participant be deemed eligible to receive an Omnipod 5 Copay Card, participant shall receive electronically one (1) Omnipod 5 Copay Card, valid for a single use, in the amount required for the participant to procure one (1) Omnipod 5 Intro Kit, which shall include:
- One (1) Omnipod 5 Controller
- Ten (10) Omnipod 5 Pods
- One (1) Omnipod 5 Quick Start Guide
- One (1) Controller charging cable
4. Product Dispense
Should participant be deemed eligible to receive a one-time dispense of Omnipod 5 Pods at no cost to them, or its authorized partner, shall dispense one (1) Omnipod 5 Intro Kit, which shall include:
- One (1) Omnipod 5 Controller
- Ten (10) Omnipod 5 Pods
- One (1) Omnipod 5 Quick Start Guide
- One (1) Controller charging cable
The Omnipod 5 Intro Kit shall be delivered to the shipping address indicated by participant in their Acknowledgment Form. Any estimate date of delivery is given solely for participant’s information and does not constitute a warranty that the Intro Kit will be delivered on said date. Participant is responsible to provide an accurate delivery address, to receive shipment of the Intro Kit and to verify the content of the Intro Kit.
Risk Statement
The Omnipod® 5 Automated Insulin Delivery System is indicated for use by individuals with Type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. The Omnipod® 5 System is intended for single patient, home use and requires a prescription. The Omnipod® 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, and Admelog®.
The Omnipod® 5 ACE Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod® 5 ACE Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values. The Omnipod® 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value.
Warning: SmartAdjust™ technology should NOT be used by anyone under the age of 2 years old. SmartAdjust™ technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
The Omnipod® 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod® 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod® 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit www.omnipod.com/safety for additional important safety information.
Warning: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.